Nymox Pharmaceutical (NYMXF) Enterprise Value (2016 - 2025)
Nymox Pharmaceutical (NYMXF) recorded Enterprise Value of $4.08 million in Q4 2025, down 56.6% from $9.38 million a year earlier.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Enterprise Value (2016 - 2025) Analysis & Trends
Starting with Q4 2016, Nymox Pharmaceutical's Enterprise Value history includes 32 quarters.
- Annual Enterprise Value has a five-year compound annual growth rate of -53.6% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $9.38 million in FY2024 (-83.0%), $55.12 million in FY2023 (+100.0%), $27.56 million in FY2022 (-75.0%) and $110.38 million in FY2021 (-41.8%).
- The Q4 2025 figure is the lowest quarterly Enterprise Value in data going back to Q4 2016.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 100.0% in Q4 2023, against a decline of 83.0% in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | Nymox Pharmaceutical | 3.84 Mn | 3.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | 9.38 Mn |
| Sep 30, 2024 | 11.18 Mn |
| Dec 31, 2023 | 55.12 Mn |
| Sep 30, 2023 | 46.99 Mn |
| Jun 30, 2023 | 17.07 Mn |
| Mar 31, 2023 | 30.42 Mn |
| Dec 31, 2022 | 27.56 Mn |
| Sep 30, 2022 | 32.37 Mn |
| Jun 30, 2022 | 33.57 Mn |
| Mar 31, 2022 | 107.12 Mn |
| Dec 31, 2021 | 110.38 Mn |
| Sep 30, 2021 | 157.46 Mn |
| Jun 30, 2021 | 123.18 Mn |
| Mar 31, 2021 | 173.07 Mn |
| Dec 31, 2020 | 189.73 Mn |
| Sep 30, 2020 | 169.83 Mn |
| Jun 30, 2020 | 252.06 Mn |
| Mar 31, 2020 | 163.65 Mn |
| Dec 31, 2019 | 151.44 Mn |
API Access
Nymox Pharmaceutical Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();